C4 TherapeuticsCCCC
那斯達克 · USD
4.14
+0.04
(+0.85%)
盤中 08/25 11:25 (UTC+8)
08/25 11:25 (UTC+8)
C4 TherapeuticsCCCC
4.14
+0.04
(+0.85%)
財務數據
損益表
- 0.03
- 0.12
- 0.15
- 0.05
- 0.07
- 0.06
- 0.11
- 0.11
- 0.06
- 0.07
- -6.81
- 295.06
- 27.95
- -66.30
- 39.81
- -10.71
- 73.76
- -1.91
- -44.15
- 7.95
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 6,641 | 6,152 | 11,016 | 11,230 | 6,463 | 7,238 | 5,177 | 15,362 | 12,006 | 3,039 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 6,641 | 6,152 | 11,016 | 11,230 | 6,463 | 7,238 | 5,177 | 15,362 | 12,006 | 3,039 |
營業費用 | 33,064 | 33,937 | 34,161 | 45,642 | 34,964 | - | - | 43,606 | 33,448 | 35,258 |
研發費用 | 24,471 | 24,606 | 24,982 | 25,989 | 26,197 | 27,072 | 32,513 | 31,838 | 23,753 | 22,533 |
推銷及管理費用 | 8,593 | 9,331 | 9,179 | 8,920 | 8,767 | 9,330 | 10,373 | 11,768 | 9,695 | 10,288 |
非經常性項目費用 | - | - | - | 10,733 | - | - | - | - | - | 2,437 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -26,423 | -27,785 | -23,145 | -34,412 | -28,501 | -29,164 | -37,709 | -28,244 | -21,442 | -32,219 |
其他收入及費用 | 2,788 | 2,656 | 2,780 | 2,246 | 2,481 | 2,842 | 3,267 | 3,578 | 3,726 | 3,858 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -23,635 | -25,129 | -20,365 | -32,166 | -26,020 | -26,322 | -34,442 | -24,666 | -17,716 | -28,361 |
所得稅 | - | - | 121 | - | - | - | 131 | - | - | - |
稅後純益 | -23,635 | -25,129 | -20,486 | -32,166 | -26,020 | -26,322 | -34,573 | -24,666 | -17,716 | -28,361 |
基本每股稅後盈餘(元) | -0.18 | -0.20 | -0.18 | -0.44 | -0.37 | -0.37 | -0.49 | -0.35 | -0.26 | -0.41 |
稀釋每股稅後盈餘(元) | -0.18 | -0.20 | -0.09 | -0.44 | -0.37 | -0.37 | -0.49 | -0.36 | -0.26 | -0.41 |
基本平均股數(千股) | 130696.00 | 126074.00 | 116784.00 | 72563.00 | 71005.00 | 70833.00 | 70606.00 | 69627.00 | 68810.00 | 68432.00 |
稀釋平均股數(千股) | 130696.00 | 126074.00 | 116784.00 | 72563.00 | 71005.00 | 70833.00 | 70606.00 | 69627.00 | 68810.00 | 68432.00 |
還原基本每股稅後盈餘(元) | -0.18 | -0.20 | -0.18 | -0.44 | -0.37 | -0.37 | -0.49 | -0.35 | -0.26 | -0.41 |
還原稀釋每股稅後盈餘(元) | -0.18 | -0.20 | -0.09 | -0.44 | -0.37 | -0.37 | -0.49 | -0.36 | -0.26 | -0.41 |
還原基本平均股數(千股) | 130,696 | 126,074 | 116,784 | 72,563 | 71,005 | 70,833 | 70,606 | 69,627 | 68,810 | 68,432 |
還原稀釋平均股數(千股) | 130,696 | 126,074 | 116,784 | 72,563 | 71,005 | 70,833 | 70,606 | 69,627 | 68,810 | 68,432 |
EBITDA(千元) | -23,529 | -25,814 | -20,800 | -32,221 | -25,986 | -26,649 | -35,043 | -25,609 | -18,933 | -29,178 |